This notice is sent to you as a shareholder of KraneShares ICAV. It is important and requires your immediate attention. If you are in any doubt as to the action to be taken, you should immediately consult your stockbroker, solicitor or attorney or other professional advisor. If you sold or otherwise transferred your holding in KraneShares ICAV, please send this notice to the stockbroker or other agent through whom the sale or transfer was effected for transmission to the purchaser or transferee.

This notice has not been reviewed by the Central Bank of Ireland (the "Central Bank") and it is possible that changes hereto may be necessary to meet the requirements of the Central Bank. The Directors are of the opinion that there is nothing contained in this notice nor in the proposals detailed herein that conflicts with the requirements of the Central Bank.

Defined terms have the same meaning as described in the prospectus of KraneShares ICAV dated 20 February 2024.

KraneShares ICAV

70 Sir John Rogerson's Quay Dublin 2

Ireland

An umbrella fund with segregated liability between sub-funds

June 27, 2025

Dear Shareholder

KraneShares ICAV

KraneShares ICBCCS S&P China 500 UCITS ETF, ISIN: IE0001QF56M0

KraneShares ICBCCS SSE STAR Market 50 Index UCITS ETF, ISIN: IE00BKPJY541 and

IE00BKPJY434

(the "Funds")

We are writing to you as a shareholder in either or both of the Funds to inform you of some changes that are being made to the Funds as further described below. These changes will take effect upon the approval by the Central Bank of updated supplements in respect of the Funds (the "Supplements"), which is expected to be 30 June 2025 or such later date as the updates to the Supplements are noted by the Central Bank (the "Effective Date").

The sub-advisor to the Funds, ICBC Credit Suisse Asset Management (International) Company Limited (the "Sub-Advisor") has undergone a name change: with effect from 13 June 2025, the Sub-Advisor's name is ICBC UBS Asset Management (International) Company Limited.

For consistency, the Funds' names will also change as outlined in the table below with effect from the Effective Date.

No Shareholder meeting or vote is necessary in connection with these matters and therefore no action is required by you.

Directors: Xiaolin Chen (UK), Feargal Dempsey, Paulo Iurcotta (Italy), Jonathan Krane (US) and Lorcan Murphy Registration number: C181441